Value proposition

Advancing AI to personalize treatment selection in depression, the leading cause of medical disability on the planet

Aifred uses AI to accomplish what was previously not possible with other methods: helping clinicians and patients make better choices when presented with a large number of treatments that are all similarly effective at the population level, but not at the individual patient level.

Along with a network of domain experts in psychiatry, we are harnessing the power of AI to better understand patterns in patient data that can predict optimal treatment.

Aifred plans to encompass a broad spectrum of mental health conditions, leveraging their treatment-agnostic AI model. At its core, Aifred is focused on bringing better mental healthcare to all.

We are a proud official IBM Watson AI XPRIZE finalist team, headquartered in Montreal, Canada.


Machine Learning, Psychiatry, and Precision Medicine